1066 related articles for article (PubMed ID: 11286301)
21. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).
Fukuchi K; Nozaki S; Yoshizumi T; Hasegawa S; Uehara T; Nakagawa T; Kobayashi T; Tomiyama Y; Yamashita S; Matsuzawa Y; Nishimura T
J Nucl Med; 1999 Feb; 40(2):239-43. PubMed ID: 10025829
[TBL] [Abstract][Full Text] [Related]
22. Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.
Valkema R; van Eck-Smit BL; van der Wall EE
J Nucl Cardiol; 1994; 1(6):546-60. PubMed ID: 9420749
[TBL] [Abstract][Full Text] [Related]
23. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
24. Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.
Wakasugi S; Fischman AJ; Babich JW; Callahan RJ; Elmaleh DR; Wilkinson R; Strauss HW
J Nucl Med; 1993 Sep; 34(9):1529-35. PubMed ID: 8355075
[TBL] [Abstract][Full Text] [Related]
25. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
[TBL] [Abstract][Full Text] [Related]
26. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction.
Franken PR; Hambÿe AS; De Geeter FW
Int J Card Imaging; 1999 Feb; 15(1):27-34. PubMed ID: 10453400
[TBL] [Abstract][Full Text] [Related]
27. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction.
Rubin PJ; Lee DS; Dávila-Román VG; Geltman EM; Schechtman KB; Bergmann SR; Gropler RJ
Am J Cardiol; 1996 Dec; 78(11):1230-5. PubMed ID: 8960580
[TBL] [Abstract][Full Text] [Related]
28. Radiopharmaceuticals for studying cardiac metabolism.
Antar MA
Int J Rad Appl Instrum B; 1990; 17(1):103-28. PubMed ID: 2155188
[TBL] [Abstract][Full Text] [Related]
29. Myocardial metabolic changes in hypertrophic cardiomyopathy.
Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
[TBL] [Abstract][Full Text] [Related]
30. Imaging of myocardial metabolism by positron emission tomography.
Rigo P; de Landsheere C; Melon P; Kulbertus H
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():847-51. PubMed ID: 2093380
[TBL] [Abstract][Full Text] [Related]
31. [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT].
Reske SN; Nitsch J; von der Lohe E; Simon HJ; Bardos P; Büll U
Z Kardiol; 1989 Apr; 78(4):262-70. PubMed ID: 2786661
[TBL] [Abstract][Full Text] [Related]
32. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
33. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
34. Detection and characterization of hibernating myocardium.
Mari C; Strauss WH
Nucl Med Commun; 2002 Apr; 23(4):311-22. PubMed ID: 11930184
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
Mori H; Sakamoto T; Ueda Y; Yano K
J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
[TBL] [Abstract][Full Text] [Related]
36. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
37. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
[TBL] [Abstract][Full Text] [Related]
38. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
39. Present assessment of myocardial viability by nuclear imaging.
Saha GB; MacIntyre WJ; Brunken RC; Go RT; Raja S; Wong CO; Chen EQ
Semin Nucl Med; 1996 Oct; 26(4):315-35. PubMed ID: 8916320
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
